Contract with Customer, Liability, Current of China SXT Pharmaceuticals, Inc. from 31 Mar 2023 to 31 Mar 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.
Summary: China SXT Pharmaceuticals, Inc. quarterly Contract with Customer, Liability, Current in USD history and change rate from 31 Mar 2023 to 31 Mar 2025.
China SXT Pharmaceuticals, Inc. Contract with Customer, Liability, Current for the quarter ending 31 Mar 2025 was $58,627, a 69% decline year-over-year.
Source SEC data: View on sec.gov

Contract with Customer, Liability, Current, Quarterly (USD)

Contract with Customer, Liability, Current, YoY Quarterly Change (%)

China SXT Pharmaceuticals, Inc. Quarterly Contract with Customer, Liability, Current (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q1 2025	$58,627	-$129,038	-69%	31 Mar 2025	20-F	31 Jul 2025	2025	FY
Q3 2024	$190,340			30 Sep 2024	6-K	28 Mar 2025	2025	Q2
Q1 2024	$187,665	+$22,131	+13%	31 Mar 2024	20-F	31 Jul 2025	2025	FY
Q1 2023	$165,534			31 Mar 2023	20-F	31 Jul 2025	2025	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.